A mid-size Cell and Gene Therapy biotech is developing AAV based gene therapies for rare diseases. In order to move one of their assets into the clinic, our client needed a partner to take on the development of this asset. Thus, Kineticos was brought on to be their third-party business development arm to identify potential partners for licensing of this asset across the globe.
For the full case study including example deliverables, click here: Gene Therapy Business Development Support
Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.